Publications by authors named "Burns W"

Importance: The effect of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative (m)FOLFIRINOX (combination leucovorin calcium [folinic acid], fluorouracil, irinotecan hydrochloride, and oxaliplatin in full or modified dosing) chemotherapy on overall survival (OS) is unclear because current studies do not account for the number of cycles of preoperative chemotherapy and adjuvant chemotherapy regimen.

Objective: To investigate the association of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative (m)FOLFIRINOX with OS, taking into account the number of cycles of preoperative chemotherapy and adjuvant chemotherapy regimen.

Design, Setting, And Participants: This retrospective cohort study included patients with localized pancreatic adenocarcinoma treated with 2 to 11 cycles of preoperative (m)FOLFIRINOX followed by resection across 48 centers in 20 countries from 2010 to 2018.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, in part resulting from cellular heterogeneity that supports overall tumorigenicity. Cancer associated fibroblasts (CAF) are key determinants of PDAC biology and response to systemic therapy. While CAF subtypes have been defined, the effects of patient-specific CAF heterogeneity and plasticity on tumor cell behavior remain unclear.

View Article and Find Full Text PDF

Objective: Effective communication is essential in delivering high-quality patient care, and in recent years, resident education has expanded to focus on nontechnical skills and communication training. The "Everything DiSC" model is a communication inventory tool used to help employers and employees gain insight into how an individual may communicate within a team and how others may perceive similarities and differences in communication styles, comprising of Dominance (D), Influence (i), Steadiness (S), and Conscientiousness (C). In this report, we describe our experience mapping the DiSC model to the Kern 6-step framework for curriculum development and summarize residents' feedback several years following its implementation.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on pancreatic acinar cell carcinoma (pACC), a rare type of pancreatic cancer, highlighting its clinical characteristics, genetic mutations, and patient survival outcomes.
  • A total of 61 patients who underwent surgery between 1999 and 2022 were analyzed, showing a median overall survival of 73 months and a recurrence-free survival of 22 months; those with oligometastatic disease had even better outcomes.
  • Significant genetic findings included mutations in core genes related to DNA repair pathways in 26% of patients, indicating potential avenues for targeted treatment.
View Article and Find Full Text PDF

Purpose: Dynamics of carbohydrate antigen 19-9 (CA19-9) often inform treatment decisions during and after neoadjuvant chemotherapy (NAT) of patients with pancreatic ductal adenocarcinoma (PDAC). However, considerable dispute persists regarding the clinical relevance of specific CA19-9 thresholds and dynamics. Therefore, we aimed to define optimal thresholds for CA19-9 values and create a biochemically driven composite score to predict survival in CA19-9-producing patients with PDAC after NAT.

View Article and Find Full Text PDF

Introduction: Emergency providers risk encountering firearms in the emergency department, but a minority report familiarity with handling firearms. It may be unsafe if unfamiliar, untrained providers attempt to remove a firearm from the clinical care space. This study assessed the efficacy of an educational intervention training resident physicians in this task.

View Article and Find Full Text PDF
Article Synopsis
  • Improved surgical techniques and therapy have enabled more patients with oligometastatic colorectal cancer to qualify for surgery, but many still experience recurrence, which varies by site and outcome.
  • A study of 195 patients who had liver metastasis resection revealed that the one-year recurrence-free survival was 46%, while overall survival rates were high at 95% for the same period; several prognostic factors for worse outcomes were identified.
  • The findings highlight the need for further research to pinpoint patients at increased risk of recurrence, potentially guiding additional preventive treatment strategies.
View Article and Find Full Text PDF

The dual tumor-suppressive and -promoting functions of TGF-β signaling has made its targeting challenging. We examined the effects of TGF-β depletion by AVID200/BMS-986416 (TGF-β-TRAP), a TGF-β ligand trap, on the tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC) murine models with different organ-specific metastasis. Our study demonstrated that TGF-β-TRAP potentiates the efficacy of anti-programmed cell death 1 (anti-PD-1) in a PDAC orthotopic murine model with liver metastasis tropism, significantly reducing liver metastases.

View Article and Find Full Text PDF

Objective: To measure the rate of LTS in resected PDAC and determine the association between predictors of OS and LTS.

Summary Background Data: Long-term survival (>5 y, LTS) remains rare in pancreatic ductal adenocarcinoma (PDAC). Multiple predictors of overall survival (OS) are known but their association with LTS remains unclear.

View Article and Find Full Text PDF

Background: The prevalence of direct-to-consumer (DTC) advertising for prescription drugs has led to concerns about how consumers interpret the medical information conveyed in these ads. One strategy for improving lay understanding of medical information involves incorporating quantitative information about a treatment's potential benefits and risks.

Objective: This literature review investigates laypersons' interpretations of statistical concepts, expanding on past reviews and including terms that may be used in DTC prescription drug advertising.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers developed a new method for matching chemotherapy regimens to pancreatic cancer patients based on chemosensitivity data from patient-derived organoids (PDOs).
  • In a study involving PDOs from 95 patients, the method successfully matched 91% of the organoids to standard chemotherapeutics and showed that well-matched patients had significantly better clinical outcomes, such as reduced tumor markers and improved survival rates.
  • The findings suggest that using PDO pharmacotyping to customize chemotherapy could lead to better treatment strategies and outcomes for patients with pancreatic ductal adenocarcinoma.
View Article and Find Full Text PDF

Objective: The objectives of the study were to assess emergency medicine (EM) physician perceptions of the EM job market 2 years after "The Emergency Medicine Physician Workforce: Projections for 2030" was published in and to examine how the workforce report may have influenced perceptions about job prospects.

Methods: A cross-sectional survey was conducted in 2022 of EM residents, fellows, and attendings at 21 practice sites. Main outcomes were perceptions of the likelihood of currently finding any job, currently finding a desirable job, and confidence in the future EM job market.

View Article and Find Full Text PDF
Article Synopsis
  • A study at Johns Hopkins Hospital compared outcomes of patients who received neoadjuvant immunotherapy before surgery with those who had upfront resection; 36 of the 92 patients received the immunotherapy.
  • The results showed that patients who underwent neoadjuvant immunotherapy had similar resection margins and recurrence-free survival rates compared to those who had upfront surgery, suggesting that this approach might help high-risk patients achieve comparable outcomes.
View Article and Find Full Text PDF

Background: Minimally invasive pancreatic surgery (MIPS), when selectively utilized, has been shown to hasten recovery with outcomes comparable to open approaches, but access may not be equitable. This study explored variation in utilization of MIPS for pancreatic cancer.

Methods: The National Cancer Database was queried to identify patients diagnosed with a primary pancreatic neoplasm from 2010 to 2020.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of preoperative chemo(radio)therapy on patients with localized pancreatic adenocarcinoma, focusing on the rare occurrence of pathological complete response (pCR), where no cancer cells are found post-surgery.
  • Conducted in 19 centers across 8 countries with 1758 participants, the research shows that only 4.8% of patients achieved pCR, which is linked to better overall survival rates compared to those who did not achieve pCR.
  • Factors influencing the likelihood of pCR included the use of multiagent chemotherapy regimens other than the (m)FOLFIRINOX treatment, highlighting the need for tailored therapeutic approaches.
View Article and Find Full Text PDF

Objectives: Although prevalent in 50%-90% of pancreatic ductal adenocarcinomas, the clinical relevance of "cancerization of ducts" (COD) remains unknown.

Methods: Pathologists retrospectively reviewed slides classifying prevalence of COD. Histopathological parameters, location of first recurrence, recurrence-free survival (RFS), and overall survival (OS) were collected from the institutional pancreatectomy registry.

View Article and Find Full Text PDF
Article Synopsis
  • * This study features four patients who displayed specific non-cancerous conditions linked to stenosis of the duct, including unique fibrosis and chronic inflammation related to past injuries.
  • * Notably, three out of the four patients had significant prior abdominal trauma from motor vehicle accidents, underscoring the long-term effects such injuries can have on the pancreas and the importance of correlating clinical history with pathology findings.
View Article and Find Full Text PDF

Background: Neoadjuvant therapy is being increasingly used for patients with pancreatic cancer. The role of adjuvant therapy in these patients is unclear. The purpose of this study was to identify clinical and pathologic characteristics that are associated with longer overall survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy.

View Article and Find Full Text PDF

Background: Molecular profiling of intrahepatic cholangiocarcinoma (ICC) can detect actionable molecular alterations and guide targeted therapies. We explore the clinical use of molecular profiling of ICC in our comprehensive multidisciplinary clinic.

Study Design: Patients with a tissue diagnosis of ICC seen between 2019 and 2023 were identified.

View Article and Find Full Text PDF

Background: Interviews for emergency medicine (EM) residency positions largely transitioned to a virtual-only format in 2020-2021. The impact of virtual interview factors on applicants' rank of programs is unknown.

Objective: We sought to assess the impact of modifiable factors in virtual interviews on applicants' rank of EM residency programs.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDA) continues to have a dismal prognosis. The poor survival of patients with PDA has been attributed to a high rate of early metastasis and low efficacy of current therapies, which partly result from its complex immunosuppressive tumor microenvironment. Previous studies from our group and others have shown that tumor-associated macrophages (TAM) are instrumental in maintaining immunosuppression in PDA.

View Article and Find Full Text PDF

Valosin-containing protein (VCP) is an AAA+ ATPase that plays critical roles in multiple ubiquitin-dependent cellular processes. Dominant pathogenic variants in VCP are associated with adult-onset multisystem proteinopathy (MSP), which manifests as myopathy, bone disease, dementia, and/or motor neuron disease. Through GeneMatcher, we identified 13 unrelated individuals who harbor heterozygous VCP variants (12 de novo and 1 inherited) associated with a childhood-onset disorder characterized by developmental delay, intellectual disability, hypotonia, and macrocephaly.

View Article and Find Full Text PDF
Article Synopsis
  • Health-related quality of life (HRQoL) is an important measure for patients with hepatocellular carcinoma (HCC) and serves as a prognostic indicator and clinical endpoint.
  • This study explored the relationship between BCLC stage, Child-Pugh score, and ECOG performance status on HRQoL, using the FACT-Hep questionnaire for assessment.
  • Findings revealed that while BCLC stages did not significantly correlate with HRQoL, patients with worse liver function (CP B) experienced a notable decline in quality of life, highlighting the need for further research on the effects of early supportive care interventions.
View Article and Find Full Text PDF

Background & Aims: BiTE (bispecific T-cell engager) immune therapy has demonstrated clinical activity in multiple tumor indications, but its influence in the tumor microenvironment remains unclear. CLDN18.2 is overexpressed in solid tumors including gastric cancer (GC) and pancreatic ductal adenocarcinoma (PDAC), both of which are characterized by the presence of immunosuppressive cells, including regulatory T cells (Tregs) and few effector T cells (Teffs).

View Article and Find Full Text PDF

Background: Pancreatic neuroendocrine tumors (PanNETs) exhibit heterogenous behavior, whereby some small tumors are aggressive with a propensity for metastasis. Detection of somatic mutations associated with aggressive biology may help with patient stratification and surgical decision-making in patients with well-differentiated PanNETs. Using next-generation sequencing (NGS), we investigated the feasibility of detecting somatic mutations in endoscopic ultrasound-guided, fine-needle aspiration (EUS-FNA) specimens and determining the mutational concordance between the EUS-FNA specimens and the primary tumors.

View Article and Find Full Text PDF